NCT01009580 - Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes | Biotech Hunter

Enrollment

447

Participants

Timeline

Start Date

November 5, 2009

Primary Completion Date

August 23, 2010

Study Completion Date

August 23, 2010

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin degludec/insulin aspart

Injected s.c. (under the skin) with the breakfast meal and main evening meal. The dose were individually adjusted. Subjects continued their pre-trial OADs (oral antidiabetic drug(s)) treatment of Metformin, the specific DPP-4 Inhibitor and Pioglitazone.

DRUG

biphasic insulin aspart 30

Trial Locations (53)

231

Novo Nordisk Investigational Site, Taipei

500

Novo Nordisk Investigational Site, Changhua

600

Novo Nordisk Investigational Site, Chiayi City

2065

Novo Nordisk Investigational Site, St Leonards

2400

Novo Nordisk Investigational Site, Copenhagen

2500

Novo Nordisk Investigational Site, Wollongong

2605

Novo Nordisk Investigational Site, Garran

2650

Novo Nordisk Investigational Site, Hvidovre

2820

Novo Nordisk Investigational Site, Gentofte Municipality

3004

Novo Nordisk Investigational Site, Melbourne

3135

Novo Nordisk Investigational Site, East Ringwood

5700

Novo Nordisk Investigational Site, Svendborg

8000

Novo Nordisk Investigational Site, Århus C

8700

Novo Nordisk Investigational Site, Horsens

9800

Novo Nordisk Investigational Site, Hjørring

10110

Novo Nordisk Investigational Site, Bangkok

10330

Novo Nordisk Investigational Site, Bangkok

10400

Novo Nordisk Investigational Site, Bangkok

10990

Novo Nordisk Investigational Site, Pulau Pinang

15110

Novo Nordisk Investigational Site, Lahti

16150

Novo Nordisk Investigational Site, Kota Bharu, Kelantan

34093

Novo Nordisk Investigational Site, Istanbul

34722

Novo Nordisk Investigational Site, Istanbul

34890

Novo Nordisk Investigational Site, Istanbul

41380

Novo Nordisk Investigational Site, Kocaeli

50200

Novo Nordisk Investigational Site, Chiang Mai

56000

Novo Nordisk Investigational Site, Cheras

62250

Novo Nordisk Investigational Site, Putrajaya

70210

Novo Nordisk Investigational Site, Kuopio

90100

Novo Nordisk Investigational Site, Oulu

110044

Novo Nordisk Investigational Site, New Delhi

132001

Novo Nordisk Investigational Site, Karnāl

400016

Novo Nordisk Investigational Site, Mumbai

560034

Novo Nordisk Investigational Site, Bangalore

600086

Novo Nordisk Investigational Site, Chennai

695011

Novo Nordisk Investigational Site, Trivandrum

700017

Novo Nordisk Investigational Site, Kolkata

4000021

Novo Nordisk Investigational Site, Mumbai

FI-28100

Novo Nordisk Investigational Site, Pori

FI-95600

Novo Nordisk Investigational Site, Ylitornio

600 013

Novo Nordisk Investigational Site, Chennai

15-445

Novo Nordisk Investigational Site, Bialystok

85-822

Novo Nordisk Investigational Site, Bydgoszcz

88-140

Novo Nordisk Investigational Site, Gniewkowo

09-400

Novo Nordisk Investigational Site, Płock

96-200

Novo Nordisk Investigational Site, Rawa Mazowiecka

01-809

Novo Nordisk Investigational Site, Warsaw

791 82

Novo Nordisk Investigational Site, Falun

651 85

Novo Nordisk Investigational Site, Karlstad

221 85

Novo Nordisk Investigational Site, Lund

222 22

Novo Nordisk Investigational Site, Lund

211 52

Novo Nordisk Investigational Site, Malmo

118 83

Novo Nordisk Investigational Site, Stockholm